Total Payments
$13,178
2024 Payments
$2,971
Companies
34
Transactions
299
Medicare Patients
21,312
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$11,071 (84.0%)
Consulting$1,950 (14.8%)
Education$157.24 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,071 | 295 | 84.0% |
| Consulting Fee | $1,950 | 1 | 14.8% |
| Education | $157.24 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $2,359 | 12 | $0 (2022) |
| ABBVIE INC. | $1,305 | 50 | $0 (2024) |
| GENZYME CORPORATION | $1,216 | 25 | $0 (2024) |
| Amgen Inc. | $896.35 | 21 | $0 (2024) |
| Incyte Corporation | $816.32 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $666.46 | 11 | $0 (2024) |
| PFIZER INC. | $624.33 | 33 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $615.48 | 14 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $591.43 | 14 | $0 (2024) |
| Dermavant Sciences, Inc. | $566.29 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,971 | 82 | Amgen Inc. ($529.10) |
| 2023 | $1,815 | 48 | ABBVIE INC. ($314.83) |
| 2022 | $3,834 | 45 | Galderma Laboratories, L.P. ($2,040) |
| 2021 | $1,384 | 39 | Lilly USA, LLC ($376.62) |
| 2020 | $217.05 | 12 | AbbVie Inc. ($80.61) |
| 2019 | $952.35 | 24 | GENZYME CORPORATION ($196.93) |
| 2018 | $930.91 | 23 | PFIZER INC. ($216.76) |
| 2017 | $1,074 | 26 | PruGen, Inc. Pharmaceuticals ($225.00) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $119.72 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $160.02 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $57.15 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $138.14 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.21 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.12 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $29.32 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 5,369 | 24,243 | $1.5M | $672,272 |
| 2022 | 35 | 6,131 | 28,359 | $1.6M | $763,182 |
| 2021 | 37 | 5,030 | 24,836 | $1.7M | $681,755 |
| 2020 | 30 | 4,782 | 22,586 | $1.6M | $540,092 |
Total Patients
21,312
Total Services
100,024
Medicare Billing
$2.7M
Procedure Codes
132
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 626 | 1,489 | $272,514 | $131,412 | 48.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 594 | 15,391 | $166,721 | $79,824 | 47.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 601 | 1,531 | $163,505 | $72,994 | 44.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 313 | 654 | $139,007 | $64,193 | 46.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 623 | 840 | $137,134 | $59,934 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 454 | 786 | $110,439 | $51,618 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 426 | $84,545 | $40,636 | 48.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 86 | 97 | $47,065 | $23,096 | 49.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 458 | 673 | $39,883 | $18,369 | 46.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 48 | 53 | $35,835 | $16,908 | 47.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 99 | 125 | $33,692 | $15,228 | 45.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 198 | 198 | $34,352 | $14,572 | 42.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 247 | 313 | $27,679 | $13,130 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $21,616 | $9,755 | 45.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 100 | 101 | $20,404 | $9,135 | 44.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 26 | 27 | $17,099 | $8,436 | 49.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 28 | 28 | $14,099 | $7,080 | 50.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 20 | 20 | $9,884 | $5,030 | 50.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 34 | 37 | $16,338 | $4,180 | 25.6% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 58 | $15,856 | $4,155 | 26.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 40 | $15,513 | $4,074 | 26.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 80 | 80 | $9,037 | $3,923 | 43.4% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 25 | 900 | $7,161 | $3,395 | 47.4% |
| 69100 | Biopsy of ear | Office | 2023 | 32 | 33 | $5,085 | $2,168 | 42.6% |
| 11422 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 25 | 25 | $7,125 | $1,864 | 26.2% |
About Dr. Anthony Huynh, MD
Dr. Anthony Huynh, MD is a Dermatology healthcare provider based in El Centro, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497766364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Huynh, MD has received a total of $13,178 in payments from pharmaceutical and medical device companies, with $2,971 received in 2024. These payments were reported across 299 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($11,071).
As a Medicare-enrolled provider, Huynh has provided services to 21,312 Medicare beneficiaries, totaling 100,024 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location El Centro, CA
- Active Since 08/10/2006
- Last Updated 11/09/2009
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497766364
Products in Payments
- EPSOLAY (Drug) $2,040
- DUPIXENT (Biological) $1,094
- Otezla (Drug) $1,009
- OPZELURA (Drug) $761.34
- SKYRIZI (Biological) $710.11
- Sotyktu (Drug) $634.51
- VTAMA (Drug) $566.29
- EUCRISA (Drug) $544.54
- ILUMYA (Biological) $445.05
- Humira (Biological) $396.21
- COSENTYX (Biological) $389.28
- Zoryve (Drug) $357.20
- ADBRY (Biological) $299.10
- DUOBRII (Drug) $252.82
- EPIDUO FORTE (Drug) $237.40
- DUPIXENT (Drug) $196.93
- Ameluz (Drug) $169.64
- RINVOQ (Biological) $167.24
- Cimzia (Drug) $153.76
- ONEXTON (Drug) $151.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.